Skip to main content
. 2022 May 11;16(Suppl 2):ii20–ii29. doi: 10.1093/ecco-jcc/jjac023

Figure 1.

Figure 1.

Clinical appearance of a patient before receiving risankizumab and after 16 weeks of treatment.